Phreesia Inc PHR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHR is a good fit for your portfolio.
News
-
Phreesia Announces Jack Callahan as New Chief Technology Officer
-
Phreesia Announces Fourth Quarter Fiscal 2024 Results
-
Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
-
New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates
-
Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results
Trading Information
- Previous Close Price
- $21.95
- Day Range
- $20.38–21.58
- 52-Week Range
- $12.07–34.98
- Bid/Ask
- $20.40 / $20.45
- Market Cap
- $1.15 Bil
- Volume/Avg
- 122,278 / 495,524
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.54
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.98%
Company Profile
Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,438
- Website
- https://www.phreesia.com
Comparables
Valuation
|
Metric
|
PHR
|
TRHC
|
CMAX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 5.19 | — | 0.20 |
Price/Sales | 3.54 | 0.78 | 0.02 |
Price/Cash Flow | — | — | — |
Price/Earnings
PHR
TRHC
CMAX
Financial Strength
|
Metric
|
PHR
|
TRHC
|
CMAX
|
|---|---|---|---|
Quick Ratio | 1.38 | 1.28 | 0.41 |
Current Ratio | 1.78 | 1.57 | 0.42 |
Interest Coverage | −74.19 | −8.04 | −11.57 |
Quick Ratio
PHR
TRHC
CMAX
Profitability
|
Metric
|
PHR
|
TRHC
|
CMAX
|
|---|---|---|---|
Return on Assets (Normalized) | −21.95% | −2.75% | −14.63% |
Return on Equity (Normalized) | −30.21% | — | −31.50% |
Return on Invested Capital (Normalized) | −29.40% | −1.87% | −10.43% |
Return on Assets
PHR
TRHC
CMAX
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Nttxts | $39.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Pljfsxrq | Dlpps | $32.4 Bil | |
SOLV
| Solventum Corp | — | Vbjzk | $11.0 Bil | |
MTHRF
| M3 Inc | — | Nmcnmvd | $8.3 Bil | |
MTHRY
| M3 Inc ADR | — | Vmtkdm | $8.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Hpqndj | $7.2 Bil | |
HQY
| HealthEquity Inc | — | Yblpyk | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Vddj | $5.0 Bil | |
DOCS
| Doximity Inc Class A | — | Yshcmk | $4.5 Bil | |
EVH
| Evolent Health Inc Class A | — | Jkmtk | $3.3 Bil |